15-min delayed · Sep 8, 3:30 PM ET · Get real-time quotes →
ANALYST CONSENSUS0 ratings
No Rating
Strong Buy00%
Buy00%
Hold00%
Sell00%
Strong Sell00%
Analyst rating coverage is not available for DXR yet.
12-MONTH PRICE TARGET
—
Average analyst target vs $10.46 current
Highest Target—
Average Target—
Lowest Target—
DXR analyst recommendation trends
86420
Sep
Oct
Nov
Dec
Jan
Feb
Strong BuyBuyHoldSellStrong Sell
RATING
SEP
OCT
NOV
DEC
JAN
FEB
Strong Buy
0
0
0
0
0
0
Buy
1
1
1
1
1
1
Hold
0
0
0
0
0
0
Sell
0
0
0
0
0
0
Strong Sell
0
0
0
0
0
0
Total
1
1
1
1
1
1
As of Feb, 1 of 1 firms rate DXR a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
DXR EPS & revenue forecast
EPS · NEXT QUARTER
$-0.06
Range $-0.06 – $-0.06 · 1 analysts
Next period, 1 analysts expect Daxor Corporation to earn $-0.06 a share (range $-0.06 – $-0.06), versus — a year earlier. Full-year consensus is $-0.21, growing to $-0.03 the year after.
REVENUE · NEXT QUARTER
—
Range — – — · 1 analysts
Revenue is expected to reach — (range — – —). Full-year consensus is $9.3M, rising to $16.4M next year.
Top analysts covering Daxor Corporation
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on DXR.
#1
Anthony Vendetti
Maxim Group · Rank #335
Buy
$22.00+110.3% to target
Overall win rate
30%
+ Follow
#2
Frank Takkinen
Lake Street · Rank #394
Buy
$23.00+119.9% to target
Overall win rate
26%
+ Follow
#3
Edward Woo
Ascendiant Capital · Rank #430
Buy
$25.00+139.0% to target
Overall win rate
26%
+ Follow
DXR stock forecast FAQ
Who is the most accurate analyst covering DXR?+
Among analysts who currently cover DXR, Anthony Vendetti of Maxim Group has the strongest overall Quantellect track record (Rank #335). Their current call is Buy with a $22.00 target.
What is Daxor Corporation's projected EPS for next quarter?+
The consensus estimate is $-0.06 per share (range $-0.06 – $-0.06) across 1 analysts. Full-year EPS is projected at $-0.21, rising to $-0.03 the following year.
How much revenue is Daxor Corporation expected to report next quarter?+
Consensus revenue is — (range — – —). Full-year revenue is projected at $9.3M, growing to $16.4M next year.
Have analysts been upgrading or downgrading DXR lately?+
As of Feb, 1 of 1 firms rate DXR a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their DXR calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
